Bile analysis in heroin overdose. by G. TASSONI et al.
CASE REPORT
Giovanna Tassoni, Ph.D.; Claudio Cacaci, M.D.; Massimiliano Zampi, Ph.D.; and Rino Froldi, Ch.D.
Bile Analysis in Heroin Overdose
ABSTRACT: Following its metabolism in the liver, morphine and its metabolites can be directly eliminated in bile. Then, they undergo the
enterohepatic cycle (EHC) and mostly reappear in the circulation. We report a case showing the presence of morphine in bile (21.3 lg ⁄mL) and hair
(4.8 ng ⁄mg) but not in blood, urine or the liver of an addict who survived in hospital for about 144 h (6 days). These data would indicate that the
EHC does not play any role about 144 h after the last injection, and directly confirms that gall bladder is a storage depot for morphine. They consti-
tute the first report of a demonstration of the effect of the EHC on morphine bioavailability in an addict, and could be considered as indication, with-
out supporting circumstantial evidence, that the morphine level in bile is related to chronic opiate use.
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Biliary excretion is an important route for the elimination of
some drugs and drug metabolites in man (1,2). A drug or drug con-
jugate excreted in bile may be reabsorbed from the gastrointestinal
tract. The conjugate may be hydrolyzed by gut bacteria liberating
the original drug which can be returned to the general circulation
determining an enterohepatic cycle (EHC). The EHC may prolong
the pharmacological effect of the drug or drug metabolites (3–5).
Furthermore, many of these drugs accumulate in bile, and the gall
bladder serves as a collection and storage depot for xenobiotics (6–
8). In fact, it has been shown that these drugs have significantly
higher concentrations in bile than in blood (7,8). Among the xeno-
biotics excreted in the bile, there are some drugs of abuse such as
opioids (7,9). Bile concentrations of morphine, the main metabolite
of heroin, have been shown to be often several-fold higher than in
blood (7,8,10). Morphine is mainly metabolized in the liver by con-
jugation with glucuronic acid to form morphine-6-glucuronide
(M6G) and morphine-3-glucuronide (M3G). In humans, about 10–
20% of morphine metabolites undergo EHC (11), and both metabo-
lites accumulate in bile to a greater extent (12,13). The EHC,
which prolongs the presence of morphine and its metabolites in
systemic circulation, complicates their pharmacokinetics and conse-
quently their detection time. In humans, very few studies have ana-
lyzed the role of EHC on morphine pharmacokinetics (12).
According to some authors, EHC may contribute to the mainte-
nance of blood and tissue levels of morphine and its metabolites in
chronic use (14). Moreover, morphine bile results are commonly
used to differentiate acute and chronic use of heroin (15–17). Epi-
demiological studies have evidenced higher bile morphine concen-
trations in established addicts, while newcomers to the practice or
those who had returned after a period of withdrawal showed low
values (15), thus indicating that the presence of high values of mor-
phine in bile could be associated with chronic opiate use (18).
However, according to some authors, bile could be a poor indicator
of chronic opiate use. They state that hair analysis could provide a
more accurate measure for determination of chronic opiate con-
sumption (19). We report a case in which a high value of bile
morphine was detected in an established addict who survived about
144 h after hospitalization due to heroin overdose. This case could
help us to clarify the role of bile in the presence of chronic use of
heroin and give some information about the role of EHC in mor-
phine pharmacokinetics of a chronic user.
Case History
A 39-year-old man known as a regular user of heroin for at least
2 years, arrived in hospital in a coma caused by a cardiocirculatory
failure due to heroin overdose, as supported by a witness statement
and confirmed by the hospital toxicological analysis. After 5 days,
his health gradually deteriorated and on the sixth day of hospitali-
zation the man died. Death was attributed to cardiac arrest.
Materials and Methods
Biological fluid (blood, urine, and bile) and samples of hair and
liver were collected during autopsy. A Triage screening was per-
formed on the urine. The urine was negative for opiates. Five gram
of liver tissue was crushed and homogenized in distilled water
(1:1) and sonicated for 30 min. The hair3nd stored in a plastic bag
at room temperature until analyzed. The four most proximal centi-
meters of the hair were used to analyze the opiate use over the
3 months preceding death. The hair was washed once with distilled
water and twice with methanol and cut into small pieces less than
1 mm long. Fifty milligram of the cut hair was weighed in conical
vials where 1 mL of 0.1 M hydrochloric acid was added together
with internal standard (nalorphine 100 lL). After incubation at
45C overnight, the sample was neutralized with 2 N sodium
hydroxide and buffered with 2 mL of phosphate buffer at pH 7.
Then the sample was centrifuged at 3500 · g for 5 min.
One milliliter of hydrochloric acid (37% in water) and 1 mL of
nalorphine solution (1 mg ⁄L), as internal standard, were added to
the samples (5 mL of blood, 3 mL of bile, and 5 g of homogenized
liver). The mixture was incubated at 125C for 20 min in a 10-mL
sealed glass tube and then kept overnight at room temperature.
After centrifugation, the solution was alkalinized to pH 8.9–9 with
sodium hydroxide (25% in water). SPE C-18, 130 mg cartridge for
hair and 200 mg for blood and bile and liver from International
Sorbent Technology (Tucson, AZ) were used. The columns were
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conditioned with 2 mL of methanol followed by 2 mL of 0.1 M
phosphate buffer at pH 7. The samples were slowly drawn through
the columns under low vacuum (at least 2 min). The columns were
washed sequentially with 2 mL of water, 3 mL of 0.1 N HCl, and
2 mL of methanol, and then dried for 5 min under full vacuum.
The analytes were eluted twice with 1 mL of a methylene chlo-
ride ⁄ isopropyle alcohol solution (8:2) with 2% ammonium hydrox-
ide, freshly made daily. The eluate was transferred to 3-mL
silanized gradual tubes and evaporated to dryness at 50C in a tem-
perature bath under a slow stream of nitrogen. The residue was
reconstructed with 50 lL of N-methyl-N-trimethyl-silyl-trifluoroace-
tamide, incubated for 15 min at 75C in sealed gradual tubes and
1 lL was injected. All the analyses were performed using a gas
chromatograph-mass spectrometry (GC ⁄MS ⁄MS) which consisted
of a Fisons 8000 series GC connected to a quadrupole Polaris
MS ⁄MS. The following operating conditions were applied: a wall
coated open tubular (WCOAT) column (fused silica,
30 m · 0.32 mm) was used and the carrier gas was helium at flow
rates of 1.5 mL ⁄min. The transfer line and the source temperature
were respectively 250 and 230C. The oven temperature profile
was 100–180C at 40C ⁄min, and then ramped at 10C ⁄minute to
a final temperature of 310C, which was held for 5 min. The injec-
tion volume was 1 lL (splitless mode). Electronic impact (70 eV)
was used for ionization. Mass spectra were recorded in the range
m ⁄z 70–500. The ions chosen were m ⁄z 429, 414, 401, 324 for
morphine-bis-trimethyl-silyl and 455, 414, 440, 324 for nalorphine-
bis-TMS.
Results and Discussion
Quantization was carried out by monitoring the abundance of
m ⁄z 429 ions (for morphine-bis-TMS) and m ⁄z 455 ions (for nalor-
phine-bis-TMS, I.S). To verify the linearity of the detector and to
calibrate the method, five calibrations were tested: 0.5, 1.0, 2.0, 4.0
and 8.0 mg ⁄L (morphine in blood and bile and liver previously
tested to be negative). Linear regression analysis of the calibration
data shows a correlation coefficient of 0.99. The limit of morphine
quantization was set at 1 ng ⁄mL with a signal to noise ratio of 15.
The quantitative results of the GC ⁄MS analysis showed that after
about 144 h from the injection of heroin there is a presence of
morphine in the bile at the value of 21.3 lg ⁄mL, but morphine
was absent in the blood and the liver. Morphine was also detected
in the hair at the value of 4.8 ng ⁄mg.
Given the current levels of sensitivity, morphine or its metabo-
lites should be detectable up to 48 h after administration in the
blood and in the urine (11,20). Longer detection times have rarely
been shown. Experiments on humans have shown that after a single
administration, morphine is detected in plasma up to 72 h (12,13).
This long circulation time of morphine and morphine glucuronide
is probably maintained by EHC (11–13). The contribution of EHC
to the total bioavailability of morphine is considerable (21), and it
is influenced by different factors. One of the most important is the
presence or absence of tolerance, which is known to influence the
metabolic rate. Until now, it is not known with any certainty just
how long it takes an addict, where tolerance is present, to clear
morphine from the EHC (11). Lack of reliable information regard-
ing the biliary excretion of drugs in man is partially due to the rela-
tive inaccessibility of the human’s biliary tract (1). The importance
of the EHC on drug pharmacokinetics is usually analyzed using
animal models (22,23) or, in humans, it is derived indirectly by
detecting the drug level in blood and urine (12,13). As far as we
are aware, our results constitute a further contribution to what we
know about the effect of the EHC on morphine bioavailability in
an addict. The presence of morphine in bile after a long time from
the assumption with the absence of morphine in blood, urine and
liver, would indicate that EHC does not play any role about 144 h
after the last injection, and confirms directly that gall bladder is a
storage depot for morphine. Moreover, the person who died was
known to be an addict. The substantial amount of bile morphine
found allows us to conclude that a high value of bile morphine can
be associated with chronic opiate use (11,15). This statement is
supported by the quantity of morphine in the hair observed in fre-
quent or chronic heroin abusers (24,25). Our results could be con-
sidered as rare evidence, without circumstantial evidence,
supporting the statement that the level of morphine in bile is related
to previous opiate use (26).
In conclusion, bile analysis can provide important information
about morphine use, especially in cases when morphine is not
detected in blood and ⁄or hair, and, for this reason it should be used
as a routine specimen in toxicological analysis.
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